(+/-)-8-PRENYLNARINGENIN(68682-02-0)
- Name: (+/-)-8-PRENYLNARINGENIN
- Synonyms:5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one;
- Molecular Formula:C20H20O5
- Molecular Weight:340.376
- CAS Registry Number:68682-02-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.68682-02-0 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.68682-02-0 8-Isopentenylnaringenin
Assay:98%Min Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by ocean shipping or clients requirement Application:An important raw material and intermediate used in Organic Synthesis, Pharmaceuticals
Min. Order:0
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] CAS No.68682-02-0 (+/-)-8-PRENYLNARINGENIN
Assay:97% Appearance:white powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 686774-65-2/5,8,13,16,21,24,29,32-Octaoxahexatriacontanedioic acid, 15,22-bis[[4-[2-[1,4-dioxo-4-[(cis-2-phenyl-1,3-dioxan-5-yl)oxy]butoxy]-1 -[[1,4-dioxo-4-[(cis-2-phenyl-1,3-dioxan-5-yl)oxy]butoxy]methyl]ethoxy]-1, 4-dioxobutoxy]methyl]-7,30-bis[[1,4-dioxo-4-[(cis-2-phenyl-1,3-dioxan-5 -yl)oxy]butoxy]methyl]-4,9,12,17,20,25,28,33-octaoxo-, bis(cis-2-phenyl-1,3-dioxan-5-yl) ester
- 686775-16-6/5,8,13,17,22,25-Hexaoxanonacosanedioic acid, 15-(3-carboxy-1-oxopropoxy)-7,23-bis[[1,4-dioxo-4-[2-[(1-oxotetradecyl )oxy]-1-[[(1-oxotetradecyl)oxy]methyl]ethoxy]butoxy]methyl]-4,9,12,18,21 ,26-hexaoxo-, 1,29-bis[2-[(1-oxotetradecyl)oxy]-1-[[(1-oxotetradecyl)oxy]methyl]ethyl] ester
- 686775-18-8/5,8,13,17,22,25-Hexaoxanonacosanedioic acid, 15-[4-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-1,4-dioxobutoxy]-7,23-bis[[1, 4-dioxo-4-(phenylmethoxy)butoxy]methyl]-4,9,12,18,21,26-hexaoxo-, bis(phenylmethyl) ester
- 686775-20-2/5,8,13,17,22,25-Hexaoxanonacosanedioic acid, 15-[3-carboxy-1-oxopropoxy]-7,23-bis[[1,4-dioxo-4-(phenylmethoxy)but oxy]methyl]-4,9,12,18,21,26-hexaoxo-, 1,29-bis(phenylmethyl) ester
- 686775-28-0/Propanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-mercapto-
- 686778-08-5/1-Piperidinyloxy, 2,2,6,6-tetraethyl-4-oxo-
- 686778-13-2/1H-Azepin-1-yloxy, 2,2,7,7-tetraethylhexahydro-4-oxo-
- 686778-17-6/4-Piperidinone, 2,2,6,6-tetraethyl-1-(1-phenylethoxy)-
- 686778-25-6/Pyrrolo[1,2-a]quinazoline-7-sulfonamide, N,N-diethyl-1,2,3,5-tetrahydro-5-oxo-
- 686778-33-6/Azepino[1,2-a]quinazoline-7-carboxaldehyde, 5,6,8,9,10,11-hexahydro-5-oxo-
- 686778-34-7/Pyrrolo[1,2-a]quinazoline-7-sulfonamide, 3-[(dimethylamino)methylene]-N,N-diethyl-1,2,3,5-tetrahydro-5-oxo-
- 686778-37-0/Pyrrolo[1,2-a]quinazolinium, 3-[(dimethylamino)methylene]-1,2,3,5-tetrahydro-4-methyl-7-nitro-5-oxo- , iodide
- 686778-56-3/Pyrrolo[1,2-a]quinazolinium, 3-[(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)ethylidene]-4-ethyl-1, 2,3,5-tetrahydro-5-oxo-, iodide
- 686778-62-1/Pyrrolo[1,2-a]quinazoline-7-sulfonamide, N,N-diethyl-3-[(3-ethyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl]-1,2,4, 5-tetrahydro-4-methyl-5-oxo-
- 686778-66-5/Pyrrolo[1,2-a]quinazoline-7-sulfonamide, 3-[(1,3-dihydro-1,3-dioxo-2H-inden-2-ylidene)methyl]-N,N-diethyl-1,2,4, 5-tetrahydro-4-methyl-5-oxo-
- 686778-67-6/1H-Indene-1,3(2H)-dione, 2-[(1,2,4,5-tetrahydro-4-methyl-7-nitro-5-oxopyrrolo[1,2-a]quinazolin-3-yl )methylene]-
- 686778-69-8/Propanedinitrile, [(1,2,4,5-tetrahydro-4-methyl-7-nitro-5-oxopyrrolo[1,2-a]quinazolin-3-yl) methylene]-
- 686779-06-6/Cyclohexanamine, N,3,3,5,5-pentamethyl-
- 686779-22-6/1,3-Benzenedicarboxamide, N,N'-bis[3-amino-2-[(2-aminoethyl)thio]-5-(1,1-dimethylethyl)phenyl]-
- 68682-02-0/(+/-)-8-PRENYLNARINGENIN
- 68683-23-8/4,7-Methano-1H-inden-5-ol, octahydro-, propanoate
- 68683-57-8/Benzenediazonium, 4-(dimethylamino)-, perchlorate
- 68683-72-7/L-Methionine, N-[N-[(1,1-dimethylethoxy)carbonyl]-L-valyl]-
- 68684-29-7/Butanedioic acid, sulfo-, 1,4-bis(2,2,3,3,4,4,5,5,5-nonafluoropentyl) ester, sodium salt
- 68684-84-4/1,3-Dioxolane, 2-(bromomethyl)-2-(2,4-dichlorophenyl)-4-(phenylmethyl)-, trans-
- 68684-89-9/1,3-Dioxolane-4-ethanol, 2-(bromomethyl)-2-(2,4-dichlorophenyl)-,methanesulfonate, cis-
- 68684-90-2/1,3-Dioxolane, 2-(bromomethyl)-2-(2,4-dichlorophenyl)-4-ethenyl-, cis-
- 68684-92-4/1H-Imidazole, 1-[[2-(2,4-dichlorophenyl)-4-(phenylmethyl)-1,3-dioxolan-2-yl]methyl]-, cis-, ethanedioate (1:2)
- 68684-98-0/1H-Imidazole, 1-[[2-(2,4-dichlorophenyl)-4-(phenylmethyl)-1,3-dioxolan-2-yl]methyl]-, trans-, ethanedioate (1:2)
- 68684-99-1/1,3-Dioxolane-4-ethanol, 2-(bromomethyl)-2-(2,4-dichlorophenyl)-,methanesulfonate, trans-